Sort
130,381 grants matching “hiv”
Role of Memory T Cell Dynamics in SIV Infection
$969,337Louis J. Picker · Oregon Health & Science University · R37 · FY2014 · AI
Biodefense/Emerging Infection Vaccine Studies
$969,286Barney Scott Graham · National Institute Of Allergy And Infectious Diseases · Z01 · FY2008 · AI
Appalachian Node
$969,141Jane M Liebschutz · University Of Pittsburgh At Pittsburgh · UG1 · FY2023 · DA
Signal Transduction In B Lymphocytes: Identification Of Key Signaling Molecules
$969,138John H Kehrl · National Institute Of Allergy And Infectious Diseases · ZIA · FY2011 · AI
Uncleaved prefusion-optimized trimers on nanoparticles as HIV vaccines
$969,072Jiang Zhu · Scripps Research Institute, The · R01 · FY2023 · AI
Uncleaved prefusion-optimized trimers on nanoparticles as HIV vaccines
$969,072Jiang Zhu · Scripps Research Institute, The · R01 · FY2022 · AI
Uncleaved prefusion-optimized trimers on nanoparticles as HIV vaccines
$969,072Jiang Zhu · Scripps Research Institute, The · R01 · FY2020 · AI
Uncleaved prefusion-optimized trimers on nanoparticles as HIV vaccines
$969,072Jiang Zhu · Scripps Research Institute, The · R01 · FY2021 · AI
Optimization of a Therapeutic HIVSIV Multi-Antigen DNA Vaccine
$968,957Kenneth C Bagley · Profectus Biosciences, Inc. · R44 · FY2016 · AI
Structural studies of native-like SOSIP trimers
$968,907Ian A Wilson · Weill Medical Coll Of Cornell Univ · P01 · FY2018 · AI
Structural studies of native-like SOSIP trimers
$968,906Ian A Wilson · Weill Medical Coll Of Cornell Univ · P01 · FY2017 · AI
MPOPHC: Quantitative design of effective testing-based policies through infection trajectory modeling
$968,765Stephen Kissler · University Of Colorado At Boulder · · FY2025 · MPS
Recovery Management Checkups for Women Offenders (RMC-WO) Experiment
$968,747Christy K Scott · Chestnut Health Systems, Inc. · R01 · FY2008 · DA
NMR Core
$968,721Angela M. Gronenborn · University Of Pittsburgh At Pittsburgh · U54 · FY2022 · AI
The Impact of Early Medical Treatment in Transgender Youth
$968,635Johanna L Olson-Kennedy · Children'S Hospital Of Los Angeles · R01 · FY2022 · HD
Characterization of the Pharmacokinetic/Pharmacodynamic (PK/PD) Profile of a Candidate HIV Prevention Drug in Rhesus Macaques
$968,613Peter Silvera · Advanced Bioscience Laboratories, Inc. · N01 · FY2022 · AI
Integrated University of Puerto Rico Clinical Trials Unit
$968,581Carmen D Zorrilla · University Of Puerto Rico Med Sciences · UM1 · FY2015 · AI
HIV Testing and Treatment to Prevent Onward HIV Transmission among High-risk MSM
$968,494Ann C Duerr · Fred Hutchinson Cancer Research Center · R01 · FY2015 · DA
ZAIMARA: Zambian Informed Motivated Aware and Responsible Adolescents and Adults
$968,475Carolyn Bolton Moore · Centre For Infectious Disease Research · UG1 · FY2023 · HD
Modeling HIV CAR-T cell trafficking and persistence in Non-Human Primates
$968,416Hans-Peter Kiem · University Of Pennsylvania · U19 · FY2021 · AI
Agricultural intervention for food security and HIV healthoutcomes in Kenya
$968,380Craig R Cohen · University Of California, San Francisco · R01 · FY2016 · MH
Technology-based Treatments for Substance Use Disorders
$968,251Lisa A Marsch · Dartmouth College · P30 · FY2013 · DA
PS12-1201 COMPREHENSIVE HIV PREVENTION PROJECT FOR HEALTH DEPTS
$968,056Marlene McNeese-Ward · Houston Department/Health/Human Srvs · U62 · FY2016 · PS
Development of two simple and robust point-of-care assays for detection and therapy monitoring of hepatitis B in resource-limited settings
$968,003Helen H Lee · Diagnostics For The Real World, Ltd · R44 · FY2017 · AI
Administrative Core
$967,981Rajesh T Gandhi · Harvard University · P30 · FY2024 · AI